Ultra-long-acting β2-adrenoceptor agonists : An emerging therapeutic option for asthma and COPD?MATERA, Maria Gabriella; CAZZOLA, Mario.Drugs (Basel). 2007, Vol 67, Num 4, pp 503-515, issn 0012-6667, 13 p.Article

The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD : A pilot studyCAZZOLA, Mario; MATERA, Maria Gabriella.Respiratory medicine. 2007, Vol 101, Num 5, pp 957-962, issn 0954-6111, 6 p.Article

Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary diseaseCAZZOLA, Mario; ROGLIANI, Paola; MATERA, Maria Gabriella et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 6, pp 775-781, issn 1465-6566, 7 p.Article

β-Adrenoceptor Modulation in Chronic Obstructive Pulmonary Disease: Present and Future PerspectivesMATERA, Maria Gabriella; CALZETTA, Luigino; CAZZOLA, Mario et al.Drugs (Basel). 2013, Vol 73, Num 15, pp 1653-1663, issn 0012-6667, 11 p.Article

Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary diseaseMATERA, Maria Gabriella; ROGLIANI, Paola; CAZZOLA, Mario et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 7, pp 961-977, issn 1465-6566, 17 p.Article

Clinical pharmacokinetics of salmeterolCAZZOLA, Mario; TESTI, Renato; MATERA, Maria Gabriella et al.Clinical pharmacokinetics. 2002, Vol 41, Num 1, pp 19-30, issn 0312-5963Article

Inhaled corticosteroids for chronic obstructive pulmonary diseaseCAZZOLA, Mario; ROGLIANI, Paola; NOVELLI, Lucia et al.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 18, pp 2489-2499, issn 1465-6566, 11 p.Article

Phosphodiesterase Inhibitors for Chronic Obstructive Pulmonary Disease: What Does the Future Hold?MATERA, Maria Gabriella; ROGLIANI, Paola; CALZETTA, Luigino et al.Drugs (Basel). 2014, Vol 74, Num 17, pp 1983-1992, issn 0012-6667, 10 p.Article

The pharmacologic treatment of uncomplicated arterial hypertension in patients with airway dysfunctionCAZZOLA, Mario; NOSCHESE, Paolo; D'AMATO, Gennaro et al.Chest. 2002, Vol 121, Num 1, pp 230-241, issn 0012-3692Article

Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patientsCAZZOLA, Mario; NOSCHESE, Paolo; SALZILLO, Antonello et al.Respiratory medicine. 2005, Vol 99, Num 5, pp 524-528, issn 0954-6111, 5 p.Article

β₂-adrenoceptor agonists: current and future directionCAZZOLA, Mario; CALZETTA, Luigino; MATERA, Maria Gabriella et al.British journal of pharmacology. 2011, Vol 163, Num 1, pp 4-17, issn 0007-1188, 14 p.Article

Comparison of a Combination of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Moderate COPD. CommentaryCAZZOLA, Mario; MATERA, Maria Gabriella; RABE, Klaus F et al.Chest. 2008, Vol 134, Num 2, issn 0012-3692, 223-225, 255-262 [11 p.]Article

Comparative effects of a two-week treatment with nebivolol and nifedipine in hypertensive patients suffering from COPDCAZZOLA, Mario; MATERA, Maria Gabriella; RUGGERI, Paolo et al.Respiration (Basel). 2004, Vol 71, Num 2, pp 159-164, issn 0025-7931, 6 p.Article

Cardiovascular disease in asthma and COPD: A population-based retrospective cross-sectional studyCAZZOLA, Mario; CALZETTA, Luigino; BETTONCELLI, Germano et al.Respiratory medicine. 2012, Vol 106, Num 2, pp 249-256, issn 0954-6111, 8 p.Article